Filing metadata

Accession number
0001213900-24-013530
Form type
Form 4
Filer
BridgeBio Oncology Therapeutics, Inc.
CIK
CIK 1869105
Filed
Feb 13, 2024
Reporting period
Feb 13, 2024
Description
Insider transaction

Explore SEC Filings Hub